Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 196 articles:
HTML format



Single Articles


    November 2022
  1. SINNER MF, von Falkenhausen AS
    A specific new biomarker for atrial fibrillation and its sequelae?
    Eur Heart J. 2022 Nov 18. pii: 6833208. doi: 10.1093.
    PubMed    


  2. GOLDENBERG L, Huang DT
    Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?
    Eur Heart J. 2022 Nov 16. pii: 6830653. doi: 10.1093.
    PubMed    


  3. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
    Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
    Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
    PubMed     Abstract available


  4. HARRINGTON J, Granger CB
    Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
    Eur Heart J. 2022 Nov 16. pii: 6830575. doi: 10.1093.
    PubMed    


  5. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    PubMed    


  6. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
    Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
    Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  7. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    PubMed     Abstract available


  8. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
    Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
    Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
    PubMed     Abstract available


  9. GAWALKO M, Sanders P
    Drug abuse and risk of atrial fibrillation: a neglected association.
    Eur Heart J. 2022 Oct 26. pii: 6774408. doi: 10.1093.
    PubMed    


  10. KAAB S, Holm H, Kirchhof P
    Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.
    Eur Heart J. 2022 Oct 21. pii: 6767860. doi: 10.1093.
    PubMed    


  11. CREA F
    New tools to predict and new therapeutic targets to treat life-threatening ventricular arrhythmias.
    Eur Heart J. 2022;43:3983-3986.
    PubMed    


  12. BRIGNOLE M, Sutton R
    Left bundle branch area pacing in perspective.
    Eur Heart J. 2022;43:4174-4176.
    PubMed    


  13. LINZ D, McIntyre WF
    Sinus rhythm: the sine qua non for rhythm control?
    Eur Heart J. 2022;43:4145-4147.
    PubMed    


  14. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
    Left bundle branch area pacing outcomes: the multicentre European MELOS study.
    Eur Heart J. 2022;43:4161-4173.
    PubMed     Abstract available


  15. VANDEWIELE F, Pironet A, Jacobs G, Kecskes M, et al
    TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
    Eur Heart J. 2022;43:4195-4207.
    PubMed     Abstract available


  16. HEIJMAN J, Dobrev D
    Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti.
    Eur Heart J. 2022;43:4208-4210.
    PubMed    


  17. MONDA E, Lioncino M, Limongelli G
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice.
    Eur Heart J. 2022 Oct 20. pii: 6763998. doi: 10.1093.
    PubMed    


  18. CADRIN-TOURIGNY J, Bosman LP, James CA
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: a practical approach to navigating the challenges of prediction models.
    Eur Heart J. 2022 Oct 20. pii: 6764102. doi: 10.1093.
    PubMed    


  19. LIN AL, Nah G, Tang JJ, Vittinghoff E, et al
    Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation.
    Eur Heart J. 2022 Oct 18. pii: 6754793. doi: 10.1093.
    PubMed     Abstract available


  20. LI J
    Long QT syndrome: long story short.
    Eur Heart J. 2022 Oct 18. pii: 6762505. doi: 10.1093.
    PubMed    


  21. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    PubMed    


    September 2022
  22. NABETA T, Kitai T, Naruse Y, Taniguchi T, et al
    Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
    Eur Heart J. 2022;43:3450-3459.
    PubMed     Abstract available


  23. MA S, Jiang J
    Pulmonary vein stenosis stenting in a patient with persistent left superior vena cava after atrial fibrillation ablation.
    Eur Heart J. 2022 Sep 16. pii: 6701795. doi: 10.1093.
    PubMed    



  24. Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
    PubMed    


  25. KOVACS B, Mayinger M, Andratschke N, Saguner AM, et al
    Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation?
    Eur Heart J. 2022;43:3279-3281.
    PubMed    


    August 2022
  26. SMEDSRUD MK, Chivulescu M, Forsa MI, Castrini I, et al
    Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Aug 29. pii: 6676380. doi: 10.1093.
    PubMed     Abstract available


  27. ECKARDT L, Sehner S, Suling A, Borof K, et al
    Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
    Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
    PubMed     Abstract available


  28. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
    Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
    Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
    PubMed     Abstract available


  29. ZEPPENFELD K, Tfelt-Hansen J, de Riva M, Winkel BG, et al
    2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Aug 26. pii: 6675633. doi: 10.1093.
    PubMed    


  30. SAGRIS D, Shantsila E, Lip GYH
    Stroke risk stratification in patients with heart failure and sinus rhythm.
    Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
    PubMed    


  31. CHEN Q, Sen B, Feng X, Yang Q, et al
    Catastrophic atrial tachycardia-induced cardiomyopathy in a teenager treated by extracorporeal membrane oxygenation and stereotactic arrhythmia radioablation.
    Eur Heart J. 2022;43:3086.
    PubMed    


  32. CORRADO D, Link MS, Schwartz PJ
    Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
    Eur Heart J. 2022;43:3029-3040.
    PubMed     Abstract available


  33. GRONDIN S, Davies B, Cadrin-Tourigny J, Steinberg C, et al
    Importance of genetic testing in unexplained cardiac arrest.
    Eur Heart J. 2022;43:3071-3081.
    PubMed     Abstract available


  34. HUQI A, Zoccali C, Giugliano RP, De Caterina R, et al
    Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
    Eur Heart J. 2022 Aug 19. pii: 6671685. doi: 10.1093.
    PubMed    


  35. MARSTON NA, Garfinkel AC, Kamanu FK, Melloni GM, et al
    A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
    Eur Heart J. 2022 Aug 18. pii: 6671409. doi: 10.1093.
    PubMed     Abstract available


  36. NARDUCCI ML, Volpe M
    Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
    Eur Heart J. 2022 Aug 8. pii: 6658237. doi: 10.1093.
    PubMed    



  37. Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Aug 5. pii: 6656112. doi: 10.1093.
    PubMed    


  38. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    PubMed    


  39. SHIN J, Han K, Jung JH, Park HJ, et al
    Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2022 Aug 4. pii: 6646730. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  40. KHAIRY P
    Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs.
    Eur Heart J. 2022;43:2695-2697.
    PubMed    


  41. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    PubMed     Abstract available



  42. Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Jul 8. pii: 6633850. doi: 10.1093.
    PubMed    


  43. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    PubMed     Abstract available


    June 2022
  44. PROTONOTARIOS A, Bariani R, Cappelletto C, Pavlou M, et al
    Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619317. doi: 10.1093.
    PubMed     Abstract available


  45. JORDA P, Bosman LP, Gasperetti A, Mazzanti A, et al
    Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619318. doi: 10.1093.
    PubMed     Abstract available


  46. GANDJBAKHCH E, Vischer AS
    Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619319. doi: 10.1093.
    PubMed    


  47. GOYAL P, Kim M, Krishnan U, Mccullough SA, et al
    Post-operative atrial fibrillation and risk of heart failure hospitalization.
    Eur Heart J. 2022 Jun 28. pii: 6617280. doi: 10.1093.
    PubMed     Abstract available


  48. MIDDELDORP ME, Albert CM
    Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.
    Eur Heart J. 2022 Jun 28. pii: 6617281. doi: 10.1093.
    PubMed    


  49. NINNI S, Longere B, Mirabel X
    Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass.
    Eur Heart J. 2022;43:2341.
    PubMed    



  50. Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.
    PubMed    


  51. WEI X, Zhou M, Chen Y, Chen M, et al
    Paroxysmal massive mitral regurgitation.
    Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
    PubMed    


  52. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    PubMed    


  53. LADOUCEUR M, Van De Bruaene A, Kauling R, Budts W, et al
    A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.
    Eur Heart J. 2022 Jun 8. pii: 6604048. doi: 10.1093.
    PubMed     Abstract available


  54. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    PubMed    


  55. BRIGNOLE M, Soranna D, Rienstra M
    Is APAF-CRT robust enough to change clinical practice?
    Eur Heart J. 2022;43:2161-2162.
    PubMed    


  56. PABEL S, Sossalla S
    Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
    Eur Heart J. 2022 Jun 2. pii: 6599046. doi: 10.1093.
    PubMed    


    May 2022
  57. JOHNSEN SP, Proietti M, Maggioni AP, Lip GYH, et al
    A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
    Eur Heart J. 2022 May 22. pii: 6590386. doi: 10.1093.
    PubMed    


  58. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  59. REMME CA, Leclercq C, Behr ER
    The European Cardiac Arrhythmia Genetics (ECGen) Focus Group.
    Eur Heart J. 2022;43:1891-1894.
    PubMed    


  60. LIUZZO G, Patrono C
    A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
    Eur Heart J. 2022 May 13. pii: 6585115. doi: 10.1093.
    PubMed    


  61. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed    


  62. CARRION-SANCHEZ I, Cobos-Gil MA
    Electrical alternans detected by an Apple Watch.
    Eur Heart J. 2022;43:1775.
    PubMed    


    April 2022
  63. ODENING KE, van der Linde HJ, Ackerman MJ, Volders PGA, et al
    Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.
    Eur Heart J. 2022 Apr 21. pii: 6571781. doi: 10.1093.
    PubMed     Abstract available



  64. Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569859. doi: 10.1093.
    PubMed    


  65. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
    A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
    PubMed    


  66. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569858. doi: 10.1093.
    PubMed     Abstract available


  67. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


  68. STIEGLIS R, Zijlstra JA, Riedijk F, Smeekes M, et al
    Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home.
    Eur Heart J. 2022;43:1465-1474.
    PubMed     Abstract available


  69. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    PubMed    


    March 2022
  70. SANDHU A, Varosy PD
    Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding?
    Eur Heart J. 2022;43:1357-1359.
    PubMed    


  71. SOLOMON SD, Claggett BL, Miao ZM, Diaz R, et al
    Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Mar 23. pii: 6552734. doi: 10.1093.
    PubMed     Abstract available


  72. CREA F
    Novel mechanistic insights into ventricular arrhythmias and sudden death.
    Eur Heart J. 2022;43:1177-1180.
    PubMed    


  73. CRIJNS HJGM, Sanders P, Albert CM, Lambiase PD, et al
    The year in cardiovascular medicine 2021: arrhythmias.
    Eur Heart J. 2022;43:1191-1197.
    PubMed    


  74. CASTILHO BM, Domingues K, Damasio AF
    Pacemaker malcapture and wide QRS complexes.
    Eur Heart J. 2022;43:1272.
    PubMed    


  75. SCHWARTZ PJ, Ackerman MJ
    Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Mar 18. pii: 6550339. doi: 10.1093.
    PubMed     Abstract available


  76. SLATER NR, Murphy KR, Sikkel MB
    VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine.
    Eur Heart J. 2022;43:1176.
    PubMed    


  77. MCINTYRE WF, Linz D
    Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
    Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
    PubMed    


  78. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    PubMed     Abstract available


  79. PRINZEN FW, Auricchio A, Mullens W, Linde C, et al
    Electrical management of heart failure: from pathophysiology to treatment.
    Eur Heart J. 2022 Mar 10. pii: 6546052. doi: 10.1093.
    PubMed     Abstract available


  80. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    PubMed     Abstract available


  81. MEHILLI J, Winhard M
    The CHADS-P2A2RC score: ready to guide the selection of treatment?
    Eur Heart J. 2022;43:1005-1007.
    PubMed    


  82. NASSER R, Meyten N, Vermeersch P, Prihadi EA, et al
    When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years.
    Eur Heart J. 2022;43:1015.
    PubMed    


    February 2022
  83. KAUR H, McIntyre WF, Belley-Cote EP
    Ablate and pace for patients with atrial fibrillation: a fragile option?
    Eur Heart J. 2022 Feb 21. pii: 6533261. doi: 10.1093.
    PubMed    


  84. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    PubMed    


  85. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    PubMed     Abstract available


  86. MUTAGAYWA RK, Chin A, Karaye K, Bonny A, et al
    Unmet needs in the management of arrhythmias among heart failure patients in Africa.
    Eur Heart J. 2022 Feb 15. pii: 6528559. doi: 10.1093.
    PubMed    


  87. TAGGART P, Nash MP, Lambiase P
    Ventricular fibrillation: combined myocardial substrate and Purkinje ablation.
    Eur Heart J. 2022 Feb 9. pii: 6525334. doi: 10.1093.
    PubMed    


  88. HAISSAGUERRE M, Cheniti G, Hocini M, Sacher F, et al
    Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
    Eur Heart J. 2022 Feb 3. pii: 6521660. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  89. CREA F
    Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer.
    Eur Heart J. 2022;43:245-248.
    PubMed    


  90. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    PubMed    


  91. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    PubMed    


  92. LAMBIASE PD, Theuns DA, Murgatroyd F, Barr C, et al
    Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
    Eur Heart J. 2022 Jan 28. pii: 6516831. doi: 10.1093.
    PubMed     Abstract available


  93. GUHA A, Alonso A, Addison D
    The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
    Eur Heart J. 2022 Jan 28. pii: 6516863. doi: 10.1093.
    PubMed    


  94. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    PubMed     Abstract available


  95. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    PubMed    



  96. Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis.
    Eur Heart J. 2022 Jan 12. pii: 6505260. doi: 10.1093.
    PubMed    


    December 2021

  97. Erratum to: Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Dec 21. pii: 6472922. doi: 10.1093.
    PubMed    


  98. NICHOLLS M
    Making connections to overcome arrhythmias.
    Eur Heart J. 2021;42:4878-4880.
    PubMed    


  99. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    PubMed     Abstract available


  100. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Dec 8. pii: 6456446. doi: 10.1093.
    PubMed    


  101. CREA F
    Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
    Eur Heart J. 2021;42:4703-4706.
    PubMed    


  102. ATTIA ZI, Harmon DM, Behr ER, Friedman PA, et al
    Application of artificial intelligence to the electrocardiogram.
    Eur Heart J. 2021;42:4717-4730.
    PubMed     Abstract available


  103. HATALA R
    Rhythm control in asymptomatic 'early' atrial fibrillation: birth of a new paradigm?
    Eur Heart J. 2021 Dec 2. pii: 6448252. doi: 10.1093.
    PubMed    


    November 2021
  104. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    PubMed    


  105. AHLBERG G, Andreasen L, Ghouse J, Bertelsen L, et al
    Genome-wide association study identifies 18 novel loci associated with left atrial volume and function.
    Eur Heart J. 2021;42:4523-4534.
    PubMed     Abstract available


  106. CERRONE M, Marron-Linares GM, van Opbergen CJM, Costa S, et al
    Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Nov 19. pii: 6431860. doi: 10.1093.
    PubMed     Abstract available


  107. MERINO JL
    Atrial fibrillation and breast cancer: Casual or causal relationship?
    Eur Heart J. 2021 Nov 14. pii: 6427544. doi: 10.1093.
    PubMed    


  108. GUHA A, Fradley MG, Dent SF, Weintraub NL, et al
    Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
    Eur Heart J. 2021 Nov 14. pii: 6427396. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  109. HEIDBUCHEL H, Van Gelder IC, Desteghe L
    ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.
    Eur Heart J. 2021 Oct 25. pii: 6409895. doi: 10.1093.
    PubMed    


  110. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 16. pii: 6398359. doi: 10.1093.
    PubMed    


  111. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    PubMed     Abstract available


  112. NAGARAJAN VD, Lee SL, Robertus JL, Nienaber CA, et al
    Artificial intelligence in the diagnosis and management of arrhythmias.
    Eur Heart J. 2021;42:3904-3916.
    PubMed     Abstract available


  113. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3932-3944.
    PubMed     Abstract available


  114. LINDE C
    Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 6. pii: 6382271. doi: 10.1093.
    PubMed    


    September 2021
  115. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    PubMed    


  116. WALSH R, Adler A, Amin AS, Abiusi E, et al
    Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
    Eur Heart J. 2021 Sep 24. pii: 6374783. doi: 10.1093.
    PubMed     Abstract available


  117. TINKER A
    Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
    Eur Heart J. 2021 Sep 20. pii: 6372801. doi: 10.1093.
    PubMed    


  118. CREA F
    The ESC Guidelines on cardiac pacing and resynchronization, and the many facets of atrial fibrillation.
    Eur Heart J. 2021;42:3411-3414.
    PubMed    


  119. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrill
    Eur Heart J. 2021 Sep 14. pii: 6370283. doi: 10.1093.
    PubMed    


  120. GLIKSON M, Nielsen JC, Kronborg MB, Michowitz Y, et al
    2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021;42:3427-3520.
    PubMed    


  121. LIN YN, Mesquita T, Sanchez L, Chen YH, et al
    Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.
    Eur Heart J. 2021;42:3558-3571.
    PubMed     Abstract available


  122. SCHWARTZ PJ, Tan HL
    Long QT syndrome, artificial intelligence, and common sense.
    Eur Heart J. 2021 Sep 11. pii: 6368899. doi: 10.1093.
    PubMed    


  123. SCHWARTZ PJ, Moreno C, Kotta MC, Pedrazzini M, et al
    Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
    Eur Heart J. 2021 Sep 10. pii: 6368299. doi: 10.1093.
    PubMed     Abstract available


  124. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    PubMed     Abstract available


  125. STEINBERG C, Krahn AD
    Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
    Eur Heart J. 2021 Sep 4. pii: 6364089. doi: 10.1093.
    PubMed    


  126. BELHASSEN B
    Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial.
    Eur Heart J. 2021 Sep 4. pii: 6364083. doi: 10.1093.
    PubMed    


  127. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  128. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    PubMed     Abstract available


  129. PRIFTI E, Fall A, Davogustto G, Pulini A, et al
    Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
    Eur Heart J. 2021 Sep 1. pii: 6361017. doi: 10.1093.
    PubMed     Abstract available


  130. ELLIOTT AD, Middeldorp ME, Linz DK
    The ins and outs of physical activity monitoring: implications for atrial fibrillation management.
    Eur Heart J. 2021 Sep 1. pii: 6361015. doi: 10.1093.
    PubMed    


    August 2021
  131. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Aug 28. pii: 6358077. doi: 10.1093.
    PubMed     Abstract available


  132. CURTAIN JP, Docherty KF, Jhund PS, Petrie MC, et al
    Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
    Eur Heart J. 2021 Aug 27. pii: 6358075. doi: 10.1093.
    PubMed     Abstract available


  133. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    PubMed     Abstract available


  134. LIGHT PE
    Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.
    Eur Heart J. 2021 Aug 27. pii: 6358226. doi: 10.1093.
    PubMed    


  135. CHIANG PH, Hsu YC, Wei JC
    Methodological considerations when discussing the fracture risk of atrial fibrillation patients taking different drug.
    Eur Heart J. 2021 Aug 11. pii: 6348063. doi: 10.1093.
    PubMed    


  136. HUANG HK, Tu YK, Loh CH
    Fracture risk associated with different oral anticoagulants in patients with atrial fibrillation: updated evidence from real-world observational studies and clinical trials.
    Eur Heart J. 2021 Aug 11. pii: 6348060. doi: 10.1093.
    PubMed    


  137. WANG N, Sun Y, Zhang H, Wang B, et al
    Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
    Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
    PubMed     Abstract available


  138. SALEM JE, Nguyen LS, Moslehi JJ, Ederhy S, et al
    Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Eur Heart J. 2021 Aug 9. pii: 6346756. doi: 10.1093.
    PubMed     Abstract available


  139. NICHOLLS M
    Reflections on EHRA 2021.
    Eur Heart J. 2021;42:2880-2881.
    PubMed    


  140. RASMUSSEN PV, Hylek E
    Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants.
    Eur Heart J. 2021 Aug 4. pii: 6339772. doi: 10.1093.
    PubMed    


  141. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    PubMed     Abstract available


  142. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    PubMed    


    July 2021
  143. WILDE AAM, Wu CI
    Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
    Eur Heart J. 2021;42:2864-2865.
    PubMed    


  144. ISHIKAWA T, Kimoto H, Mishima H, Yamagata K, et al
    Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Eur Heart J. 2021;42:2854-2863.
    PubMed     Abstract available


  145. ALHUMAID W, Yogasundaram H, Senaratne JM
    Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
    Eur Heart J. 2021;42:2868.
    PubMed    


  146. GUASCH E, Nattel S
    Ageing, comorbidities, and the complex determinants of atrial fibrillation in athletes.
    Eur Heart J. 2021 Jul 23. pii: 6327053. doi: 10.1093.
    PubMed    


  147. ADABAG S, Madjid M, Cheng A
    An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
    Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
    PubMed    



  148. Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
    Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
    PubMed    


  149. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available


  150. BUNTING KV, Stanbury M, Tica O, Kotecha D, et al
    Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
    Eur Heart J. 2021;42:2411-2414.
    PubMed    


    June 2021

  151. Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
    Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
    PubMed    


  152. VAN DER REE MH, Postema PG
    What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
    Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
    PubMed    


  153. SCHNABEL RB, Fabritz L, Kirchhof P
    Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
    Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
    PubMed    



  154. Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
    PubMed    


  155. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
    Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
    Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
    PubMed     Abstract available


  156. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  157. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  158. PARK S, Lee S, Kim Y, Lee Y, et al
    Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
    Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
    PubMed     Abstract available


  159. BENN M
    Atrial Fibrillation And Chronic Kidney Disease.
    Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
    PubMed    


  160. TOMSITS P, Clauss S, Kaab S
    Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
    Eur Heart J. 2021;42:1972-1975.
    PubMed    


  161. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed     Abstract available


  162. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    PubMed     Abstract available


  163. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    PubMed     Abstract available


  164. STEINBERG C, Davies B, Mellor G, Tadros R, et al
    Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
    PubMed     Abstract available


  165. CSENGERI D, Sprunker NA, Schnabel RB
    Alcohol and atrial fibrillation: dose matters, not so much the type.
    Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
    PubMed    


  166. MESSERLI FH, Dobner S
    Alcohol and atrial fibrillation: not all drinks are created equal.
    Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
    PubMed    


  167. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


  168. GNECCHI M, Sala L, Schwartz PJ
    Precision Medicine and cardiac channelopathies: when dreams meet reality.
    Eur Heart J. 2021;42:1661-1675.
    PubMed     Abstract available


  169. DELISE P
    Risk stratification in Brugada syndrome: the challenge of the grey zone.
    Eur Heart J. 2021;42:1696-1697.
    PubMed    


  170. PROBST V, Goronflot T, Anys S, Tixier R, et al
    Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
    Eur Heart J. 2021;42:1687-1695.
    PubMed     Abstract available


  171. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
    Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
    Eur Heart J. 2021;42:1714.
    PubMed    


    April 2021
  172. GALIUTO L, Volpe M
    Cryoblation as first-line treatment of new-onset atrial fibrillation?
    Eur Heart J. 2021;42:1543-1544.
    PubMed    


  173. SMOLDEREN KG, Burg MM
    A broken heart after child loss.
    Eur Heart J. 2021;42:1496-1498.
    PubMed    


  174. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021
  175. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
    Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
    Eur Heart J. 2021;42:1270-1272.
    PubMed    


  176. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
    Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
    Eur Heart J. 2021;42:1273-1274.
    PubMed    


  177. YOUNIS A, Goldenberg I
    Extending the MADIT-ICD benefit score to heterogenous heart failure populations.
    Eur Heart J. 2021 Mar 18. pii: 6177051. doi: 10.1093.
    PubMed    


  178. POSTEMA PG, Walsh R, Bezzina CR
    Illuminating the path from genetics to clinical outcome in Brugada syndrome.
    Eur Heart J. 2021;42:1091-1093.
    PubMed    


  179. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
    Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
    Eur Heart J. 2021;42:1073-1081.
    PubMed     Abstract available


  180. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
    Brugada syndrome genetics is associated with phenotype severity.
    Eur Heart J. 2021;42:1082-1090.
    PubMed     Abstract available


  181. IRIART X, Metras A, Coiffic A, Thambo JB, et al
    Late device-related thrombus after left atrial appendage closure: never let your guard down.
    Eur Heart J. 2021;42:1050.
    PubMed    


    February 2021
  182. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    PubMed    


  183. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
    The year in cardiovascular medicine 2020: arrhythmias.
    Eur Heart J. 2021;42:499-507.
    PubMed     Abstract available


  184. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
    Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
    Eur Heart J. 2021;42:544.
    PubMed    


    January 2021
  185. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    PubMed    


  186. HAMILTON GW, Lim HS
    Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
    Eur Heart J. 2021;42:133.
    PubMed    


    December 2020
  187. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed     Abstract available


  188. WILDE AAM, Lodder EM
    Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
    Eur Heart J. 2020;41:4523-4524.
    PubMed    


  189. HAMILTON RM, Chatterjee D, Saguner AM
    Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
    Eur Heart J. 2020;41:4521-4522.
    PubMed    


    November 2020
  190. VERHAMME P, Budts W, Van de Werf F
    Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
    Eur Heart J. 2020;41:4178-4180.
    PubMed    


    April 2020
  191. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  192. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  193. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    PubMed    


  194. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  195. PACKER M
    What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
    Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  196. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
    Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
    Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: